Abeona therapeutics announces clinical data presentations at upcoming scientific congresses

New york and cleveland, oct. 13, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced two presentations of previously disclosed clinical data at upcoming scientific congresses in october 2021. the presentations include a poster presentation on the long-term wound healing and pain relief data from the phase 1/2a eb-101 trial at the 2021 pediatric dermatology research alliance (pedra) annual conference, held virtually october 14-15, 2021; and an oral presentation on the pivotal trial of the company's investigational aav-based gene therapy abo-102 in mps iiia at the virtual 28th annual congress of the european society of gene & cell therapy (esgct), october 19-22, 2021.
ABEO Ratings Summary
ABEO Quant Ranking